Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Oregon Brain Bank
MS Research Australia Brain Bank
Help Keep MSDF Alive!
Abnormal Venous Outflow Dynamics May Not Be Implicated in MS
No Go for MS Combination Therapy
Podcasts discuss new MS treatment strategy
Sera Laboratories International
MS Research Study Alert: Did You Have A Brain Biopsy To Confirm Your Diagnosis? Investigators Seeking Tissue Samples Previously Obtained from People with MS and Similar Diseases
First-Attack Multiple Sclerosis Targets Gray Matter
Eight cases of insular sclerosis of the brain and spinal cord.
Exploiting the EBV-MS Link to Quell Secondary Progressive Disease
High Noon at the Th17 Corral
Papers: 2 May 2014 - 9 May 2014
MS Research Roundup: March 31, 2014
MS Patient, Ph.D.: Exercise in MS: Good or Bad?
Gavin Giovannoni's "Tube Map" for MS
Request for Applications for Collaborative Network Awards from the Progressive MS Alliance
NeuroBioTec
Damage to Strategic Brain Regions May Explain Fatigue in MS
Stem Cells Stop the Train of MS Damage in Mice
National MS Society (US) Research Grants
ω-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS Study): A Randomized, Double-Blind, Placebo-Controlled Trial.
Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission.
Multiple Sclerosis Society of Canada's MS Scientific Research Foundation
Centre d'Etude, de Ressource et de Veille en Neuropathologie (CERVEN) de la Salpêtrière, Paris
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »
